top of page
Latest News
Jan 20, 2023
Neuro-Oncology Advances Publishes About Neosoma's Technology
Neosoma HGG's (NS-HGlio) Technology and Development was Recently Published in Neuro-Oncology Advances
Dec 9, 2022
Neosoma Participates in Big Data Federated Learning Study
UPenn-led study brought together almost 6,500 brain cancer MRIs from 71 sites on 6 continents to study the benefits of federated-learning-based AI on glioblastoma segmentation.
Nov 17, 2022
AI-Powered Neuro-Oncology Clinical Trials
Neosoma's strategic partnership with Calyx enables faster, more precise tumor assessment in brain cancer clinical trials.
Nov 7, 2022
Neosoma Announces Partnership with Nuance Communications
Neosoma Announced Today its AI Solutions Connect to the Nuance Precision Imaging Network
Sep 29, 2022
Neosoma Announces FDA 510(k) Clearance for Neosoma HGG
Neosoma Announced Today It Has Received U.S. Food and Drug Administration (FDA) 510(k) Clearance for Its First AI-Based Neuro-Oncology Software, Neosoma HGG
bottom of page